Understanding Cannabis Genetics and Chemovars Selection for Improved Therapeutic Outcomes in Patients

When: Wednesday, 12 July 2023

Time: 7 pm (AEST)

Cost: Free

The webinar has ended.

However, you can watch the recording in the Medihuanna Community.

Join Emily Rigby in an exclusive webinar presented by Medihuanna, focusing on Understanding Cannabis Genetics and Chemovars Selection for Improved Therapeutic Outcomes in Patients.

Emily Rigby

Emily Rigby is a research scientist and passionate advocate for medicinal cannabis – promoting education, patient access, research, innovation, industry development, efficient production and regulatory reform.

Since 2016, Emily has played an integral role in developing the Australian medicinal cannabis industry, including establishing one of Australia’s first licenced medical cannabis cultivation and research facilities and releasing Australian grown cannabis medicines into local and export markets. Emily is also assisting in developing international cannabis industries.

Emily is on the Board of the Australian Medicinal Cannabis Association (AMCA) and Director at Protected Cropping Australia (PCA) – Australia’s peak industry body for hydroponic and greenhouse growers. Emily was President of the Australian Society of Horticultural Science from 2017 to 2021 and is a 2016 Nuffield Australia Farming Scholar. Emily was recognised as Australia’s 2021 ‘Woman of Weed’ in the Australian Cannabis Awards for her contribution to female leadership in the cannabis space.

Emily has a diverse range of expertise including propagation and cultivation methods, cannabis genetics, facility design, licensing & regulatory compliance, strategic planning, patient access, education, marketing and research from plant to patient.

Emily is dedicated to removing the stigma surrounding the Cannabis plant and facilitating the global cannabis industry.

Cannabis genetics is a rapidly evolving field with the potential to revolutionize the way we use cannabis for medicinal purposes

Understanding the therapeutic effects of cannabis genetics and the presence of specific cannabinoids and terpenes, is important to tailor treatment to individual patients.

This presentation emphasises the importance of cannabis genetics and chemovar selection for medical professionals who prescribe medicinal cannabis dried flower to their patients.

  • Cannabis genetics and chemovar selection play a crucial role in determining the therapeutic effects of medicinal cannabis.
  • Different cannabis chemovars (ie strains) have different chemical profiles, which can affect their medicinal properties.
  • Medical professionals need to understand the different chemovars and their effects on various medical conditions to make informed decisions when prescribing medicinal cannabis.
  • Understanding different cannabinoid and terpene profiles can help medical professionals select chemovars best suited for specific therapeutic outcomes.
  • Importance of ongoing research and education in the field of medicinal cannabis to improve patient outcomes and ensure safe and effective use.

Overall, cannabis genetics and chemovar selection are an important component of cannabis medicine and can play a significant role in the therapeutic effects of the plant.

Claim CPD Hours

Medihuanna is a CPD approved education provider, and this activity has been approved by the RACGP (Activity ID: 548208). Upon completing this activity, you will be eligible to claim CPD hours. The activity will include the following CPD allocation which will be uploaded to the RACGP dashboard.

Educational Activity: 1 hour

CPD Accredition Provider badge

© Medihuanna Pty Ltd, 2023. All rights reserved.